Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (261-270 of 284) with videos related to

Pageof 29
Sort By:
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Cell|September 17, 2020
High Potency of a Bivalent Human V<sub>H</sub> Domain in SARS-CoV-2 Animal ModelsWei Li, Alexandra Schäfer, Swarali S Kulkarni, et al.
JCI Insight|November 8, 2022
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cellsKim Anthony-Gonda, Alex Ray, Hang Su, et al.
The Journal of Clinical Investigation|July 19, 2005
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patientsJoseph A Kovacs, Richard A Lempicki, Igor A Sidorov, et al.
Nature Medicine|November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapyTerry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Pageof 29

Showing results (261-270 of 284) with videos related to

Sort By:
Pageof 29
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Cell|September 17, 2020
High Potency of a Bivalent Human V<sub>H</sub> Domain in SARS-CoV-2 Animal ModelsWei Li, Alexandra Schäfer, Swarali S Kulkarni, et al.
JCI Insight|November 8, 2022
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cellsKim Anthony-Gonda, Alex Ray, Hang Su, et al.
The Journal of Clinical Investigation|July 19, 2005
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patientsJoseph A Kovacs, Richard A Lempicki, Igor A Sidorov, et al.
Nature Medicine|November 21, 2017
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapyTerry J Fry, Nirali N Shah, Rimas J Orentas, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2023
Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing SarcomaBrian Mooney, Gian Luca Negri, Taras Shyp, et al.
Nature|November 4, 2021
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Nature|November 8, 2023
Targeting of intracellular oncoproteins with peptide-centric CARsMark Yarmarkovich, Quinlen F Marshall, John M Warrington, et al.
Pageof 29